Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VK2735 for Weight Management in Obese or Overweight Adults With Type 2 Diabetes Mellitus
NCT07868939Phase 3Not yet recruiting
- Sponsor
- Viking Therapeutics
- Start
- Nov 2026
- Primary completion
- Oct 2028
01
Overview
A Phase 3 trial of VK-2735 in obesity, sponsored by Viking Therapeutics. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
VK-2735
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07868939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07868939.